Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Simcere Pharmaceutical Group Ltd
2096Current price
7.08 HKD
-0.02 HKD (-0.28%)
Last closed
7.12 HKD
Company
www.simcere.com
ISIN
HK0000658531
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Hong Kong Stock Exchange
Capitalization
16 567 394 542 HKD
Yield for 12 month
-1.67 %
1Y
3Y
5Y
10Y
15Y
2096
Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. The company focusses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN, a simnotrelvir tablets/ritonavir tablets. The company also offers promotion services for pharmaceutical products. It has a strategic regional licensing partnership with Vivoryon Therapeutics N.V. to develop and commercialize SIM0801 and other drugs in the Greater China region. In addition, the company engages in the manufacture of pharmaceutical ingredients; and property management business. Simcere Pharmaceutical Group Limited was founded in 1995 and is headquartered in Nanjing, China. Address: No. 699-18, Xuanwu Road, Nanjing, China, 210042
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
68.51 HKDP/E ratio
–Dividend Yield
2.47 %Current Year
+7 133 852 762 HKD
Last Year
+6 822 159 624 HKD
Current Quarter
+3 648 357 588 HKD
Last Quarter
+3 907 590 323 HKD
Current Year
+5 380 941 731 HKD
Last Year
+5 394 649 536 HKD
Current Quarter
+2 765 205 254 HKD
Last Quarter
+3 081 823 570 HKD
Key Figures 2096
1 year
3 years
5 years
10 years
EBITDA
1 150 684 171 HKD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
4.79 %
PEG Ratio
–
Return On Equity TTM
-13.81 %
Wall Street Target Price
68.51 HKD
Revenue TTM
6 347 799 768 HKD
Book Value
2.73 HKD
Revenue Per Share TTM
Dividend Share
0.16 HKD
Quarterly Revenue Growth YOY
-7.9 %
Dividend Yield
2.47 %
Gross Profit TTM
3 924 783 707 HKD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
-79.2 %
Profit Margin
-17.39 %
Dividend Analytics 2096
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
47 %Dividend History 2096
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.18
Ex Dividend Date
18.06.2024
Forward Annual Dividend Yield
2.61 %
Last Split Factor
–
Payout Ratio
60.24 %
Last Split Date
–
Dividend Date
–
Stock Valuation 2096
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
13.4409
Enterprise Value Revenue
2.15
Price Sales TTM
2.6099
Enterprise Value EBITDA
11.8387
Price Book MRQ
2.2443
Financials 2096
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2096
For 52 weeks
4.8 HKD
7.64 HKD
50 Day MA
6.51 HKD
Shares Short Prior Month
–
200 Day MA
5.77 HKD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart